WednesdayDec 06, 2023 11:15 am

Podcast: Jewelry Maker GEMXX Corp. (GEMZ) Enjoys Rapid Growth Thanks to Gold Interest, Focus on Vertical Mine-to-Market Integration

GEMXX Corporation is unique as a jewelry maker with important Canadian mining assets, supporting its mine-to-market operations dealing in gold and the rare Ammolite gemstone Amid recent market fluctuations, gold continues to maintain a strategic profile as an investment safe haven, with consumption continuing at a historic pace GEMXX is riding high on recent “explosive” revenue growth and a no long-term debt position, looking forward to fulfilling select goals to improve its overall production, uplisting to a major exchange and aggressively seeking out strategic acquisitions to add revenue and / or reduce its costs A new NetworkNewsAudio News Podcast and…

Continue Reading

TuesdayDec 05, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Interim Results in Ongoing GLP-1 Human Pilot Study

Lexaria, a global innovator in drug delivery platforms, just announced additional positive interim results from its ongoing GLP-1 human pilot study The study seeks to provide an early-stage indication of whether DehydraTECH(TM) processing could improve oral drug delivery characteristics of the GLP-1 drug semaglutide Lexaria’s DehydraTECH GLP-1 showed a 2.9% to 14.6% blood glucose level reduction relative to baseline, compared to 1.3% to 6.7% for the control group The DehydraTECH GLP-1 group also only saw a 5.3% spike in glucose levels after having a standardized meal at the 240-minute mark and a snack at the 360-minute mark, compared to 22.7%…

Continue Reading

MondayDec 04, 2023 10:30 am

Diamond Lake Minerals Inc. (DLMI) Riding Growing Sea Swell Favoring Digital Assets, Security Tokens

Security tokens are becoming increasingly popular as minimized risk entry points for digital infrastructure markets, with smart algorithms beginning to effectively deal with redemption dispute resolution concerns Utah-based Diamond Lake Minerals recently shifted its focus from mining holdings to digital assets and security tokens offerings, and has seen its market interest rise in the process DLMI aims to build an industry-agnostic, vertically integrated holding company that helps its subsidiaries develop self-sufficiency while offering an inroad to experienced investors wary of digital asset involvement — functioning as a “generational wealth” bridge Some market insiders see tokenization as the launch of a…

Continue Reading

FridayDec 01, 2023 9:45 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Is ‘One to Watch’

In November 2023, Vision Marine filed with the SEC to sell 370,000 ordinary shares priced at $4.05 in a private placement The company in November 2023 reported its receipt of a purchase order from boat manufacturer Wired Pontoons for 25 units of its E-Motion 180E powertrain system Vision Marine announced in October 2023 delivery of E-Motion 180E powertrain technology to boat manufacturer Groupe Beneteau, to be integrated on the Four Winns H2e Bowrider model In August 2023, a catamaran powered by a Vision Marine powertrain set an electric boat world speed record of 116 mph at the Lake of the…

Continue Reading

FridayDec 01, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Building a Global Presence with Superior Delivery Technology for Wide Range of Drugs and Active Pharmaceutical Ingredients

Lexaria, a global innovator in drug delivery platforms, has, through its patented DehydraTECH(TM) technology, proven to enhance the performance of several categories of fat-soluble active molecules and drugs Since 2018, human clinical studies on the technology have yielded positive results, ultimately earning Lexaria 37 granted patents globally, with many more pending around the world With the strides made so far, Lexaria looks to grow its revenue and commercial opportunities through licensing Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains committed to its mission to provide healthier delivery methods of drugs and other Active Pharmaceutical Ingredients (“APIs”).…

Continue Reading

Contact us: (512) 354-7000